July 30, 2016 7:18 AM ET


Company Overview of Vantia Ltd

Executive Profile

David McGibney M.D., Ph.D., FRCP,FFPM

Board Advisor, Vantia Ltd
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships


Dr. David McGibney, M.D., Ph.D., FRCP,FFPM, served as Pre-Clinical and Clinical Advisor at Cellzome AG. Dr. McGibney is an Independent Consultant in Pharmaceutical R & D and is a Consultant Pharmaceutical Physician. Previously, he was a Venture Partner at Imperial Innovations Group plc. Dr. McGibney was a clinical and drug development advisor to Imperial Innovations Ltd. After five years in academic medicine, he joined Pfizer in 1982. During his time at Pfizer, he served ...

Corporate Headquarters

Epsilon House
Southampton, Hampshire SO16 7NS

United Kingdom

Phone: 44 11 7916 7693
Fax: 44 23 8001 5945

Board Members Memberships

There is no Board Members Memberships data available.


Unknown/Other Education
University of Leeds Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Vantia Ltd, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.